← Leaderboards
Meagan Joy McManus
Children'S Hosp Of Philadelphia
$2,632,290
Attributed
$2,632,290
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $555.1K · FY2020–24$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,632,290 · 1
By mechanism
R01$2,632,290 · 1
Top collaborators
No co-investigators on record.
Most similar at Children'S Hosp Of Philadelphia
Same institution · by research overlap
- Amy Tara Waldman$1,766,727
- John M Maris$30,818,378
- Karin Borgmann-Winter$1,128,899
- Jessica Anne Panzer$187,488
Others in their field
Other Emerging Leaders on “Direct Application”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Martha Hering · Westat, Inc.$57,098,843
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- John Hobbs · Suny At Stony Brook$41,239,084
- Christopher Bee · Suny At Stony Brook$41,239,084
Research focus
Direct ApplicationAgingAging BrainAcetovanilloneAnimal ModelAttenuatedAutomobile DrivingAutonomic DysfunctionAlpha SynucleinBehavior TestBioenergeticsBiological MarkersBlood - Brain Barrier AnatomyBrainBrain DiseasesCellsClinicClinical ApplicationClinical BiomarkersClinically RelevantClinical Trials DesignCognitionDesignDisease Diagnosis
Grant awards (5)
Superoxide-sensitive radiotracer as a predictive biomarker of Parkinson's disease progression$516,194
R01 · FY2024 · NS · contact PI
Superoxide-sensitive radiotracer as a predictive biomarker of Parkinson's disease progression$521,995
R01 · FY2023 · NS · contact PI
Superoxide-sensitive radiotracer as a predictive biomarker of Parkinson's disease progression$513,957
R01 · FY2022 · NS · contact PI
Superoxide-sensitive radiotracer as a predictive biomarker of Parkinson's disease progression$525,051
R01 · FY2021 · NS · contact PI
Superoxide-sensitive radiotracer as a predictive biomarker of Parkinson's disease progression$555,093
R01 · FY2020 · NS · contact PI